$RPM

RPM International Sees Sales Growth In Q1, FY27; Boosts Share Buyback - Update

RPM International reported Q4 results and forecast consolidated sales growth of mid-single digits for Q1 and 3% to 4% for FY2027. Its board authorized a $700.0 million increase to its existing common stock repurchase program, on top of $114.8 million remaining. The stock was about $101.23 pre-market, down $0.30.

Original reporting
Published Jul 22, 2026, 1:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 22, 2026, 1:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$RPM
Bullish
medium confidence
Mentioned
$RPM
Relevance
7/10
AlphAI data visualization · based on rttnews.com
Decision brief

The 30-second read

$RPMBullishMed
01

Why it matters

New Q1 and FY2027 sales guidance plus a $700M increase to the buyback program can change near-term expectations for revenue trajectory and shareholder yield.

02

Market read

Traders can reassess RPM’s growth outlook and capital return expectations immediately based on the disclosed guidance ranges and buyback increase.

03

What to watch

The article does not provide margin, cash flow, or segment detail; traders may need to wait for the full earnings release to assess whether growth quality supports the repurchase pace.

Relevance 7/10Novelty 7/10Timing: pre-market today after Q4 results, with new Q1 and FY2027 sales guidance plus buyback authorization

Background

RPM reported Q4 results and used the update to provide forward sales growth expectations and expand its share repurchase authorization.

Company-level read

Ticker impact

$RPMBullishMedium confidence
Context

RPM guided Q1 sales to mid-single-digit growth and FY2027 sales to 3% to 4%, and authorized a $700M buyback increase.

Expected impact

Moderately positive bias for the stock as investors price in steadier growth and higher capital return.

Evidence & confidence

The article discloses specific forward sales growth ranges and a sizable incremental buyback authorization, both direct drivers of earnings power and shareholder yield.

Market effects

May modestly reinforce sentiment toward industrial coatings and building-products peers that trade on steady end-demand and capital return.

No specific regional read-through beyond US industrial cyclicals.

Limited; guidance and buyback are company-specific with no stated global macro catalyst.

Counterpoint

The FY2027 sales growth range (3% to 4%) is relatively modest, so the buyback may be more about capital allocation than accelerating fundamentals.

Key entities

  • RPM International, Inc.

    Provided Q1 and FY2027 consolidated sales growth guidance and authorized an additional $700M for its share repurchase program.

Related articles

$RPMMed

RPM (RPM) Q4 2026 Earnings Call Transcript

RPM held its Q4 2026 earnings call, reporting consolidated sales up 7.2% to a record and record adjusted EBIT and adjusted EPS, driven by engineered solutions, pricing to offset inflation, and M&A. Management said SG&A optimization actions are on track for $75 million in fiscal 2027 savings and expects raw-material inflation of 5% to 6% in Q1 2027 and 6% to 8% in Q2.

$RPMMed

RPM INTERNATIONAL INC/DE/ (RPM): Results of Operations and Financial Condition

RPM INTERNATIONAL INC/DE/ (RPM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d141573dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 RPM Reports Record Fiscal 2026 Fourth-Quarter and Full-Year Results • Record fourth-quarter sales of $2.23 billion increased 7.2% compared to the prior year • Fourth-quarter net income of $221.2 million, diluted EPS of $1.7

$XLABMed

Exascale Labs Holdings Inc. (XLAB): Results of Operations and Financial Condition

Exascale Labs Holdings Inc. (XLAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Exascale Labs Holdings Inc. Reports 111% Revenue Growth for Full Fiscal Year 2026 and Provides Business Update Following Successful Nasdaq Listing ● Fiscal year 2026 revenue increased 111% to $14.8 million, compared to $7.0 million in fiscal year 2025, driven by acce